IL2 and atherosclerosis: Others showed that treatment using an IL-2/anti-IL-2 monoclonal antibody (mAb) attenuates atherosclerosis via expansion of regulatory T cells (Tregs)29 and evidence exists that also Type 2 innate lymphoid cells might play an important role in IL-2 mediated reduction of atherosclerosis30.